Nature Nanotechnology (nature-nanotechnology)
Journal positioning
Nature Nanotechnology publishes papers that represent a significant conceptual advance in nanoscience and nanotechnology — research that opens a new direction, overturns an established assumption, or demonstrates an entirely new capability at the nanoscale. It is among the most selective venues in the physical sciences; the bar is not incremental performance improvement but a result that the broad nanoscience community will recognize as a milestone. The readership spans physicists, chemists, materials scientists, and biomedical engineers who work at the nanoscale. This skill is a fit / venue-selection / re-framing tool. It does not replace the journal's current official submission guidelines. Before submitting, re-check the live author instructions on the Nature Portfolio site.
When to trigger
- The author names Nature Nanotechnology as the target venue for a high-significance nanoscale advance.
- A manuscript demonstrates a new physical principle, new functionality, or new nano-bio capability that reshapes how the community thinks about a problem.
- The author is choosing between Nature Nanotechnology, ACS Nano, and Nature Materials and needs to assess the significance tier required.
- The author needs Nature Nanotechnology's desk-reject heuristics and alternative routing before submitting.
Scope & topic fit
- Nanoscale quantum phenomena: single-electron/photon control, quantum coherence, spin manipulation at the nanoscale with direct measurement and functional relevance.
- 2D materials and van der Waals heterostructures when a new physical property or device paradigm is established, not incremental device fabrication.
- Molecular machines and functional nanostructures that exhibit emergent behavior not predictable from bulk analogues.
- Nano-bio: delivery, sensing, or imaging at the single-cell or single-molecule level, where the nanoscale mechanism is indispensable and the biological or medical significance is clear.
- Nanophotonics and nanoplasmonics with new physical phenomena (beyond engineering optimization of known effects).
- DNA nanotechnology, programmable self-assembly, or structural nanotechnology when a new architectural or functional principle is demonstrated.
Method & evidence bar
- The conceptual advance must be clearly identifiable: a paper that improves device efficiency by a factor without revealing a new principle will not clear the bar.
- Direct nanoscale characterization at the relevant length scale is mandatory; ensemble-averaged measurements that do not isolate the nanoscale mechanism are insufficient.
- For functional claims, the demonstration must be compelling and statistically supported; single-device or single-particle demonstrations require rigorous statistical treatment across multiple independently prepared samples.
- Theoretical/computational work must be directly coupled to experiment — either as the basis for a surprising experimental prediction that is verified, or as an explanation of an unexpected experimental observation.
- Reproducibility: synthesis protocols and device fabrication must be described in sufficient detail for replication; Nature's reporting summary requirements apply.
- Claims involving biomedical relevance require appropriate in-vivo or mechanistically validated in-vitro evidence — cell viability alone is insufficient for drug delivery claims.
Structure & house style
- Nature Nanotechnology publishes Articles and Letters (re-check current type options); both are short by disciplinary standards, with a large fraction of the evidence in Extended Data and Supplementary Information.
- The main text must be written for the broad nanoscience community, not for specialists: the significance of the advance must be intelligible to a physicist unfamiliar with the specific chemical system, and vice versa.
- The introduction should state the conceptual gap in one or two paragraphs, the advance in one sentence, and reserve literature review for Supplementary Information.
- Extended Data figures carry essential controls and supporting experiments; SI carries full methods and secondary data.
- Nature's reporting summary (Methods) and data/code availability statement are required; re-check current policy for specific deposition requirements.
- A "Significance statement" or equivalent plain-language summary may be required; re-check current editorial requirements.
Official-submission checklist
- Before giving submission-ready advice, read
../../resources/source-basis.md and ../../resources/official-source-map.md; start from the official source anchors for this journal family, then cite the current journal-specific page you checked.
- Search the live site for "Nature Nanotechnology author instructions" or "Nature Portfolio submission guidelines" and follow the current version.
- Re-check article-type definitions, word/figure limits, Extended Data limits, and Supplementary Information scope.
- Re-check the Nature reporting summary requirements (statistics, reproducibility, blinding, sample sizes, animal/human research).
- Confirm data and code availability statement requirements and any deposition obligations for atomic coordinates, sequence data, or device fabrication files.
- Re-check competing-interests, funding, author-contribution, and AI-use disclosure requirements.
- Re-check preprint policy and embargo/press-office coordination requirements.
- If the live official instructions conflict with this skill, the official instructions win.
Pre-submission self-check
Common desk-reject triggers
- Incremental performance improvement in a known system (better efficiency, higher sensitivity) without a new mechanistic or conceptual insight.
- Nanoscale application claims without direct nanoscale mechanistic evidence — bulk characterization used to infer nanoscale behavior.
- A paper addressed to a narrow specialist audience that would be a milestone within a subfield but does not open a new direction for nanoscience broadly.
- Insufficient statistical treatment: a compelling single-device or single-particle result without multi-sample replication.
- Overstated biomedical claims: "nanoparticle for cancer treatment" without direct mechanistic in-vivo evidence at the nanoscale.
- Writing resembles an ACS Nano or Advanced Materials article (comprehensive characterization, solid work) but lacks the conceptual leap needed for Nature-portfolio tier.
Re-routing decision
- Excellent nanoscience but below the conceptual-advance threshold for Nature Nanotechnology →
acs-nano (broader significance window) or Nano Letters (ACS; more technical, faster).
- Materials advance where nano framing is secondary →
nature-materials (conceptual) or advanced-materials (breadth).
- Chemistry-driven nanoscience with sustainability/energy framing →
chem or joule.
- Nano-bio advance with clinical translational emphasis →
nature-biomedical-engineering or nature-medicine.
Output format
[Fit] High / Medium / Low (one-line reason)
[Target] Nature Nanotechnology
[Topic tags] <2–3 closest topics>
[Method/evidence] <does the paper demonstrate a new nanoscale principle or capability with direct nanoscale evidence?>
[Top risk] <the single most likely reason for rejection>
[Official items to re-check] <article type / word limit / Extended Data / reporting summary / data deposition / ethics / disclosures>
[Re-route suggestion] <if not a fit, a better-matched venue>